Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Infections × lime × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 2 Breast Neoplasms 2 Weight Loss 1 Uterine Cervical Dysplasia 1 Polycystic Ovary Syndrome 1 Papillomavirus Infections 1 Obesity 1 Insulin Resistance 1 Infertility, Female 1 Infections 1 Cognitive Dysfunction 1

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 8 Ciprofloxacin 6 Fluconazole 3 Daptomycin 3 Antibiotic Prophylaxis 3 gamma-Globulins 2 Voriconazole 2 Vancomycin 2 Trimethoprim 2 Sulfamethoxazole 2 Saline Solution 2 Ribavirin 2 Peripheral Blood Stem Cell Transplantation 2 Pentetic Acid 2 Melphalan 2 Itraconazole 2 Immunoglobulins, Intravenous 2 Fosfomycin 2 Ethanol 2 Cyclophosphamide 2 Cefazolin 2 Amoxicillin-Potassium Clavulanate Combination 2 ziprasidone 1 tocilizumab 1 telavancin 1 telaprevir 1 talquetamab 1 soybean oil, phospholipid emulsion 1 peginterferon alfa-2a 1 monalizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02346227 2018-10-12

KINVAV

Universiteit Antwerpen

Phase 3 Completed

Uterine Cervical Dysplasia, Infections, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡